Abstract
Fifty-eight semicarbazone and pyrazole derivatives of curcumin have been developed as potential mitigation agents to treat acute radiation syndrome (ARS). Pyridyl (D12, D13), furyl (D56), and phenyl (D68) derivatives of curcumin semicarbazones were found to provide the highest dose modifying factors (DMF) with respect to survival in sub-TBI (bone marrowsparing) exposures in mouse models. To investigate the basis for the mitigating effects of these agents on ARS, we examined their oxidation potentials and radical scavenging properties in comparison to other semicarbazone and pyrazole curcumin derivatives with less effective DMFs. Comparisons between D12, D13, D56, and D68 and other semicarbazone and pyrazole derivatives of curcumin did not show a sufficient difference in reducing properties and hydrogen atom donating properties for these properties to be the basis of the dose modifying activities of these compounds. Therefore, their DMFs likely reflect structure-activity relationship(s),wherein interaction with key receptors or alteration of enzyme expression result in modifications of cellular or tissue responses to radiation, rather than on the derivatives’ ability to modify radiation-induced flux of free radicals through direct interaction with these radicals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jarrett DG, Sedlak RG, Dickerson WE, Reeves GI (2007) Medical treatment of radiation injuries - Current US status. Radiat Meas 42:1063-1074
Jagetia GC (2007) Radioprotection and radiosensitization by curcumin. Adv Exp Med Biol 595:301-320
Venkatesan N, Punithavathi D, BabuM(2007) Protection from acute and chronic lung diseases by curcumin. Adv Exp Med Biol 595:379-405
Wang Y-J, Pan M-H, Cheng A-L, Lin L-I, Ho Y-S, Hsieh C-Y, Lin J-K (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15:1867-1876
Dutta S, Padhye S, Priyadarsini KI, Newton C (2005) Antioxidant and antiproliferative activity of curcumin semicarbazone. Bioorg Med Chem Lett 15:2738-2744
Selvam C, Jachak SM, Thilagavathi R, Chakraborti AK (2005) Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents. Bioorg Med Chem Lett 15:1793-1797
Furniss BS, Hanneford AJ, Smith WG, Tatchell AR: Vogel’s Text book of Practical Organic Chemistry, 5th Edition, Longman Publishers Pvt. Ltd.: 1989
Amolins MW, Peterson LB, Blagg BSJ (2009) Synthesis and evaluation of electron-rich curcumin analogues. Bioorg Med Chem 17:360-367
Prieto P, Pineda M, Aguilar M(1999) Spectrophotometric quantitation of antioxidant capacity through the formation of a Phosphomolybdenum Complex: Specific application to the determination of vitamin E. Analytical Biochem 269:337-341
Lamaism JI, Ptitjean-Freytet C, Carnet A (1991) DPPH scavenging activity. Pharm Acta Helv 66:185-188
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this paper
Cite this paper
Swarts, S.G. et al. (2011). Antioxidant Properties of Select Radiation Mitigators Based on Semicarbazone and Pyrazole Derivatives of Curcumin. In: LaManna, J., Puchowicz, M., Xu, K., Harrison, D., Bruley, D. (eds) Oxygen Transport to Tissue XXXII. Advances in Experimental Medicine and Biology, vol 701. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7756-4_39
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7756-4_39
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7755-7
Online ISBN: 978-1-4419-7756-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)